2Q loss reduction trend better than expectation
China Sportswear Sector – We expect prudent guidance but decent margins
China Pharmaceutical & Healthcare: Expecting global funding recovery in the coming quarters
Expect Shengyi to enter Nvidia supply chain in 2024
Turnaround is here but weaker than expected
Expect domestic business to rebound from 2025
Expect $3.5bn CB dilutive effect to be short-term
China Property Sector – Property+ Weekly: Can we expect post-CNY recovery?
1H23 Preview: weak revenue amid industry headwinds; expect smartphone recovery in 2H23E
Apple FY1Q23 miss on macro and supply chain issues; Expect weakness to persist in near term